Latest News for: lly

Edit

The Smart Way to Own LLY: Collect 8.8% Before You Even Buy (Insight Guru Inc)

Public Technologies 21 Mar 2026
) The Smart Way to Own LLY ... March 21st, 2026by Trefis Team LLY ... At about $906.7 a share, Eli Lilly (LLY) is trading about 18% below its 52W high ... LLY Stock Insights ... LLY closes below $640 You'll be obligated to buy 100 shares at $640.
Edit

Why Eli Lilly (LLY) Shares Are Plunging Today

The Call 17 Mar 2026
What Happened? ... LLY) fell 6.3% in the afternoon session after investment bank HSBC downgraded the stock to a sell-equivalent "reduce" rating from "hold," citing concerns that its shares were "priced to perfection." ... ONE MORE THING ... More News. View More ... .
Edit

Final Trade: LLY and GDX

CNBC 24 Feb 2026
The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders ... .
Edit

Eli Lilly (LLY) Stock Is Up, What You Need To Know

The Call 23 Feb 2026
What Happened? ... LLY) jumped 3.8% in the afternoon session after a major competitor, Novo Nordisk, announced that its experimental obesity drug failed to show it was as effective as Lilly's tirzepatide in a head-to-head clinical trial ... More News ... .
Edit

Why Eli Lilly (LLY) Shares Are Getting Obliterated Today

The Call 05 Feb 2026
What Happened? ... LLY) fell 7.4% in the morning session after the company discontinued three clinical pipeline assets, including a gene therapy for dementia acquired through a billion-dollar deal ... We’ve identified the next one ... More News ... Tickers LLY NVO ... .
Edit

The $1 Trillion Apothecary: A Deep-Dive Research Report on Eli Lilly (LLY)

The Call 05 Feb 2026
LLY) stands as a paradigm-shifting titan in the global healthcare landscape ... LLY trades at a premium forward P/E ratio of approximately 35x 2026 estimates, reflecting the market's high expectations for its oral GLP-1 pipeline ... Tickers LLY NVO.
Edit

LLY stock jumps 9%: Why Eli Lilly stock is soaring today - Mounjaro, Zepbound sales ...

The Economic Times 04 Feb 2026
LLY stock today ... .
Edit

LLY stock jumps 9%: Why Eli Lilly stock is soaring today - Mounjaro, Zepbound sales drive massive earnings

The Times of India 04 Feb 2026
LLY stock​ today ... .
Edit

Eli Lilly (LLY) Stock Trades Up, Here Is Why

The Call 04 Feb 2026
What Happened? ... LLY) jumped 10% in the afternoon session after the company reported fourth-quarter 2025 results that beat Wall Street expectations and issued an upbeat forecast for 2026, driven by high demand for its weight-loss drugs ... More News ... .
Edit

Eli Lilly (NYSE:LLY) Reports Strong Q4 CY2025, Stock Soars

The Call 04 Feb 2026
LLY) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 42.6% year on year to $19.29 billion ... Eli Lilly (LLY) Q4 CY2025 Highlights. ... LLY) discovers, develops, and ...
Edit

Eli Lilly (LLY) Reports Q4: Everything You Need To Know Ahead Of Earnings

The Call 03 Feb 2026
Global pharmaceutical company Eli Lilly (NYSE. LLY) will be reporting earnings this Wednesday before market hours. Here’s what to expect ... Is Eli Lilly a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members ... .
Edit

Why Eli Lilly (LLY) Stock Is Up Today

The Call 21 Jan 2026
What Happened?. Shares of global pharmaceutical company Eli Lilly (NYSE. LLY) jumped 3.5% in the afternoon session after the U.S ... This designation aimed to speed up the development and review process for drugs designed to treat serious conditions ... D.R ... .
Edit

The Trillion-Dollar Pharmacopeia: Eli Lilly’s (LLY) Dominance in the Age of Incretins

The Call 19 Jan 2026
LLY) ... LLY is up approximately 38%, significantly outperforming the S&P 500 ... In 2021, LLY was trading around $160; by late 2025, it became the first pharmaceutical company to cross the $1 trillion market cap threshold.
Edit

Why Eli Lilly (LLY) Stock Is Down Today

The Call 15 Jan 2026
What Happened?. Shares of global pharmaceutical company Eli Lilly (NYSE. LLY) fell 4.5% in the afternoon session after the U.S. Food and Drug Administration (FDA) delayed its decision on the company's new oral weight-loss pill, Orforglipron ... More News ... .
Edit

The Trillion-Dollar Pharmacist: A 2026 Deep Dive into Eli Lilly (LLY)

The Call 09 Jan 2026
LLY) has transitioned from a stalwart of the American pharmaceutical industry to a global financial phenomenon ... Over the last decade, LLY has been one of the strongest performers in the S&P 500.

Article Search

tools
×
×
×
×